Recent advance in treatments of infectious intracranial aneurysms
10.3760/cma.j.cn115354-20210825-00540
- VernacularTitle:感染性颅内动脉瘤的治疗研究进展
- Author:
Longjiang ZHOU
1
;
Xin ZHANG
Author Information
1. 扬州大学附属医院医学影像中心,扬州 225009
- Keywords:
Infectious intracranial aneurysm;
Anti-infective treatment;
Surgical treatment;
Endovascular treatment
- From:
Chinese Journal of Neuromedicine
2022;21(4):429-432
- CountryChina
- Language:Chinese
-
Abstract:
Infectious intracranial aneurysm (IIA) is a kind of rare infectious neurovascular disease. The most common cause of IIA is bacterial embolism after acute or subacute infective endocarditis. The most common clinical symptoms of IIA include subarachnoid hemorrhage or intracranial hematoma resulted from aneurysm rupture, which has high disability and mortality rate. The treatment options for IIA mainly include anti-infective therapy, surgical treatment and endovascular interventional therapy. However, due to pathogenesis differences and aneurysm size, shape, location and rupture, the treatment plans for IIA patients need to be implemented individually. This article mainly focuses on the research progress of the different treatments of IIA in order to provide references for IIA clinical treatment.